Snap-8 vs SYN-AKE
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Acetyl Octapeptide-3, SNAP-8
SNAP-8 (Acetyl Octapeptide-3) is a synthetic eight-amino-acid topical cosmetic peptide, an extended cousin of Argireline that adds two residues to the same SNAP-25 mimic sequence. It is marketed as a needle-free way to soften expression lines, especially on the forehead and around the eyes. It is a cosmetic ingredient, not an approved drug, and the human evidence behind it is thin and mostly comes from the manufacturer.
Also: Dipeptide diaminobutyroyl benzylamide diacetate, SYN-AKE
SYN-AKE is DSM's trade name for dipeptide diaminobutyroyl benzylamide diacetate, the 'snake venom' peptide in a lot of anti-wrinkle creams. The marketing says it mimics Waglerin-1, a toxin from the temple viper. To be clear: there is no venom in it. It is a tiny synthetic molecule, and the evidence that it relaxes wrinkles comes almost entirely from the manufacturer.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Snap-8 | SYN-AKE |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The pitch is that SNAP-8 imitates the tip of SNAP-25, a protein nerves use to dock and release acetylcholine, the signal that tells facial muscles to contract. By competing for a spot in the SNARE complex that drives that release, the peptide is meant to dial down muscle firing and therefore the creasing those muscles cause, a gentler, reversible echo of how Botox works. The honest catch is that this is a proposed mechanism inferred from its sequence and from cell and test-tube work, not something confirmed to happen in living facial muscle after you rub on a cream. SNAP-8 is hydrophilic and fairly large, so getting enough of it down through the skin to reach muscle is the central unsolved problem. | DSM describes SYN-AKE as a reversible blocker of the muscle-type nicotinic acetylcholine receptor, the receptor on muscle that acetylcholine opens to make it contract. Block it, the theory goes, and facial muscles relax a little. That is the real mechanism of Waglerin-1, a 22-amino-acid viper toxin that independent research shows selectively blocks the adult form of this receptor. SYN-AKE itself is a much smaller molecule (beta-alanine, proline and diaminobutyric acid with a benzylamide end, under 500 daltons), and the claim that it does the same thing comes from the manufacturer's own cell test, where innervated muscle cells contracted less. Even DSM's older material calls the binding 'probable'. As with Argireline, there is no independent proof that a cream gets enough of it to facial muscle to matter. |
| Common Dosing | Limited community data available See research protocols | 1-4% of the SYN-AKE solution in a finished product Once or twice daily |
| Administration | Topical (serums, creams) | Topical (serums, creams) |
| Typical Duration | Ongoing use for maintained effects | 28 days in the manufacturer study; ongoing use to maintain any effect |
| Best Time to Take | Evening (topical) | Morning and/or evening, on clean skin |
Possible Side Effects May vary by individual |
|
|
| Research Summary | There is no robust independent clinical trial library for SNAP-8 specifically. Most of the impressive numbers you see, such as large percentage drops in wrinkle depth over four weeks, trace back to manufacturer literature rather than peer-reviewed, placebo-controlled studies. The science is best understood by looking at its parent peptide Argireline (acetyl hexapeptide-8), where the picture is genuinely mixed: the original 2002 Blanes-Mira study reported roughly 30 percent wrinkle-depth reduction with a 10 percent cream, but a later independent split-face human trial using VISIA imaging found no statistically significant difference between the peptide side and placebo. A 2025 review of acetyl hexapeptide-8 also flagged that skin-penetration data conflict sharply and that none of the in vivo studies actually confirmed muscle inhibition, the supposed mechanism. So for SNAP-8, treat the marketing claims with caution: plausible idea, real cosmetic-ingredient status, weak and largely company-sourced human proof. | DSM's brochure reports two pieces of data. In vitro, 0.5 mM of the peptide cut the contraction frequency of innervated muscle cells. In vivo, a 4% SYN-AKE cream was compared with placebo in 15 volunteers per group (aged 40-60), applied twice daily for 28 days, with reductions of roughly 15-21% in skin roughness and wrinkle measures and a headline of 'up to 52%' wrinkle reduction in the best responders. A US patent also describes a double-blind study in 59 women aged 40-55 reporting smaller pores and less shine after 28 days, but that is a patent filing, not a peer-reviewed paper. A 2020 review of cosmetic peptides states plainly that there are no scientific papers describing clinical studies of this peptide, so the efficacy story rests on company data. Bottom line: a well-tolerated cosmetic ingredient with a catchy story. The venom angle is marketing, and the 'up to 52%' number is a best case from a 15-person company study, not a typical result. |
Frequently Asked Questions: Snap-8 vs SYN-AKE
What is the difference between Snap-8 and SYN-AKE?
Snap-8 is a skin & hair peptide that snap-8 (acetyl octapeptide-3) is a synthetic eight-amino-acid topical cosmetic peptide, an extended cousin of argireline that adds two residues to the same snap-25 mimic sequence. it is marketed as a needle-free way to soften expression lines, especially on the forehead and around the eyes. it is a cosmetic ingredient, not an approved drug, and the human evidence behind it is thin and mostly comes from the manufacturer. SYN-AKE is a skin & hair peptide that syn-ake is dsm's trade name for dipeptide diaminobutyroyl benzylamide diacetate, the 'snake venom' peptide in a lot of anti-wrinkle creams. the marketing says it mimics waglerin-1, a toxin from the temple viper. to be clear: there is no venom in it. it is a tiny synthetic molecule, and the evidence that it relaxes wrinkles comes almost entirely from the manufacturer. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Snap-8 or SYN-AKE?
Neither is universally "better" - the choice depends on your specific goals. Snap-8 is typically used for skin & hair purposes, while SYN-AKE is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Snap-8 and SYN-AKE be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Snap-8 and SYN-AKE together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.